Opvee: Is It the New Narcan?
By BrightView BrightView Meet The Editorial Team Published: June 2, 2023 Updated: February 9, 2024 When the FDA approved Narcan nasal spray for over-the-counter nonprescription use, it became the first naloxone product approved for use without a prescription. This has opened the door for other brands to become more widely available. The latest is Nalmefene, an opioid antagonist medication known by the brand name Opvee. Scheduled for release no sooner than October 2023, Opvee is a nasal spray from the manufacturer, Opiant Pharmaceuticals, which was recently acquired by rival Indivior,…
Details